INAVA and inflammatory bowel disease: The polymorphism of C1orf106 is a susceptibility factor for inflammatory bowel disease (IBD), and the decrease of C1orf106 protein expression could lead to the loss of intestinal mucosa barrier integrity, resulting in increased susceptibility to IBD (32).